Patents by Inventor Philip James Dolan, III

Philip James Dolan, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies recognizing tau
    Patent number: 11958896
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Grant
    Filed: May 2, 2018
    Date of Patent: April 16, 2024
    Assignee: Prothena Biosciences Limited
    Inventors: Robin Barbour, Svetlana Alexander, Mark Renz, Shuning Gai, Tarlochan S. Nijjar, Philip James Dolan, III, Philip Payne
  • ANTIBODIES RECOGNIZING SORTILIN
    Publication number: 20240117039
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: October 26, 2023
    Publication date: April 11, 2024
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • ANTIBODIES RECOGNIZING SORTILIN
    Publication number: 20240117040
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: October 26, 2023
    Publication date: April 11, 2024
    Inventors: Andriani Ioannou, Tarlochan S. Nijjar, Philip James Dolan, III, Wagner Zago
  • Antibodies recognizing tau
    Patent number: 11926659
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Grant
    Filed: February 22, 2021
    Date of Patent: March 12, 2024
    Assignee: Prothena Biosciences Limited
    Inventors: Tarlochan S. Nijjar, Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
  • METHODS OF USING ANTIBODIES RECOGNIZING TAU
    Publication number: 20240018226
    Abstract: The invention provides methods of treating taupathies such as Alzheimer's disease with antibodies that bind to human tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: August 28, 2023
    Publication date: January 18, 2024
    Applicant: Prothena Biosciences Limited
    Inventor: Philip James Dolan, III
  • ANTIBODIES RECOGNIZING SORTILIN
    Publication number: 20230348588
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: December 22, 2022
    Publication date: November 2, 2023
    Inventors: Philip James Dolan, III, Andriani Ioannou, Wagner Zago, Tarlochan S. Nijjar
  • Tau Immunotherapy
    Publication number: 20230340094
    Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: April 21, 2023
    Publication date: October 26, 2023
    Applicant: Prothena Biosciences Limited
    Inventors: Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20230250161
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: February 17, 2023
    Publication date: August 10, 2023
    Applicant: Prothena Biosciences Limited
    Inventors: Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
  • ANTIBODIES RECOGNIZING SORTILIN
    Publication number: 20230235048
    Abstract: The invention provides antibodies that specifically bind sortilin. The antibodies inhibit or delay pathologies associated with changes in progranulin levels and associated symptomatic deterioration.
    Type: Application
    Filed: June 23, 2021
    Publication date: July 27, 2023
    Inventors: Andriani IOANNOU, Tarlochan S. NIJJAR, Philip James DOLAN, III, Wagner ZAGO
  • Tau immunotherapy
    Patent number: 11643457
    Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: May 9, 2023
    Assignee: Prothena Biosciences Limited
    Inventors: Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
  • TAU IMMUNOTHERAPY
    Publication number: 20230126858
    Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 27, 2023
    Inventors: Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
  • Antibodies recognizing tau
    Patent number: 11584791
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Grant
    Filed: November 4, 2020
    Date of Patent: February 21, 2023
    Assignee: Prothena Biosciences Limited
    Inventors: Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20220372118
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: November 4, 2020
    Publication date: November 24, 2022
    Applicant: Prothena Biosciences Limited
    Inventors: Robin Barbour, Philip James Dolan, III, Yue Liu
  • Tau immunotherapy
    Patent number: 11492393
    Abstract: The invention provides antibodies to tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Grant
    Filed: July 20, 2020
    Date of Patent: November 8, 2022
    Inventors: Peter Seubert, Philip James Dolan, III, Yue Liu, Robin Barbour
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20220275067
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: February 7, 2020
    Publication date: September 1, 2022
    Applicant: PROTHENA BIOSCIENCES LIMITED
    Inventors: Philip James DOLAN, III, Tarlochan S. NIJJAR, Svetlana ALEXANDER, Robin BARBOUR, Stephen Jed TAM
  • METHODS OF USING ANTIBODIES RECOGNIZING TAU
    Publication number: 20220267426
    Abstract: The invention provides methods of treating taupathies such as Alzheimer's disease with antibodies that bind to human tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: February 14, 2022
    Publication date: August 25, 2022
    Inventor: Philip James Dolan, III
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20220153821
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: November 8, 2019
    Publication date: May 19, 2022
    Inventors: Tarlochan S. NIJJAR, Robin BARBOUR, Philip James DOLAN, III, Yue LIU, Svetlana ALEXANDER, Mark E. RENZ
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20220089702
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: May 2, 2018
    Publication date: March 24, 2022
    Applicant: PROTHENA BIOSCIENCES LIMITED
    Inventors: Robin BARBOUR, Svetlana ALEXANDER, Mark RENZ, Shuning GAI, Tarlochan S. NIJJAR, Philip James DOLAN, III, Philip PAYNE
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20210261652
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: February 22, 2021
    Publication date: August 26, 2021
    Applicant: PROTHENA BIOSCIENCES LIMITED
    Inventors: Tarlochan S. Nijjar, Robin BARBOUR, Philip James DOLAN, III, Yue LIU, Svetlana ALEXANDER, Mark E. RENZ
  • ANTIBODIES RECOGNIZING TAU
    Publication number: 20210130449
    Abstract: The invention provides antibodies that specifically bind tau. The antibodies inhibit or delay tau-associated pathologies and associated symptomatic deterioration.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 6, 2021
    Applicant: PROTHENA BIOSCIENCES LIMITED
    Inventors: Robin Barbour, Philip James Dolan, III, Yue Liu, Svetlana Alexander, Mark E. Renz